Tesamorelin dosage and how quickly it left the blood
Drug makers chose a daily shot for the trials. Here are the amounts studied, where each shot went, and what the blood figures mean.
What the tesamorelin dosage tells you
Drug makers needed the natural brain hormone to reach the pea-size gland under the brain, so later trials used a 2 milligram shot into belly fat once each day. Tesamorelin stayed in blood for only about half an hour to an hour, while the liver-made growth protein IGF-1 stayed raised longer.
I give these amounts so you can read the studies. They aren’t directions for taking tesamorelin. Lab-study material isn’t patient medicine. Your own doctor can talk with you about treatment.
Which tesamorelin dosage researchers tested
Both main Phase 3 trials—late studies that checked the main benefit and watched for harm—used the same tesamorelin dosage: 2 milligrams under the skin once each day [1][2]. The 26-week trial used it [1]. So did the 52-week study [2], the liver-fat trial [3], and every study group in the 2026 review [14]. Most of the known benefit came from that amount.
Researchers also tested a daily 1 milligram shot. It appeared in one study of thought in older adults and one diabetes study focused on blood sugar. The daily 2 milligrams has far more study behind it [4]. A newer tesamorelin medicine puts more drug into less liquid, so the daily shot has less fluid. That changes shot size, not the older study result. The older 2 milligrams form still provides most of the proof. That 2 milligrams amount anchors the main findings.
These are trial facts, not instructions for you. Lab material isn’t the finished approved drug. The studies put the shot in the fat layer under the belly skin [1]. They didn’t test a pill, a tablet under the tongue, or a patch. Tesamorelin is a small protein chain, so your stomach would break down a swallowed dose.
Why tesamorelin was made as a powder
Freezing out the water leaves the approved medicine as dry powder. Its label says to keep it cold and sets a deadline after a clinic adds liquid. Those are label facts, not mixing steps.
The makers faced another problem. An enzyme, a substance in blood, cuts apart the natural brain hormone within minutes. A small chemical guard slows the enzyme’s cut [7]. Lab material may not match its label for strength or cleanliness. None of these facts tells you to prepare or inject a shot.
How fast tesamorelin leaves the blood
For 14 days, one study gave 1-2 milligrams a day to healthy adults and people receiving HIV care, then used their blood samples to calculate 1,060 liters per hour. That isn’t liquid moving through a person. It is a math label showing that the drug level fell very fast. By day 14, the body absorbed about 13% more of each dose than on day 1. For you, the finding means age and body size didn’t shift the blood timing enough to affect care [6]. Other medical sources say the blood level fell by half in about 26-38 minutes.
A short time in blood doesn’t mean the hormone effect ended just as fast. Tesamorelin starts one brief rise in growth hormone. IGF-1, a liver-made growth protein, stays raised after tesamorelin is gone [4][10]. That longer hormone effect is why researchers could study one daily shot.
The added chemical piece slows the enzyme’s cut and buys more time in blood [7]. Even then, tesamorelin leaves the blood quickly.
What tesamorelin blood timing means for prescription care
Population PK modeling reported apparent plasma clearance of ~1,060 L/h with no clinically relevant demographic covariates [6]; secondary sources describe a terminal half-life on the order of ~26-38 minutes. Despite that rapid clearance, the downstream IGF-1 elevation it triggers persists across the dosing interval, which is why once-daily dosing was studied [4].
Blood timing does not decide access: Promise Peptides (mypromise.com) now prescribes prescription-only tesamorelin, with a licensed U.S. clinician considering each request and accepting or declining it. The patient must be in the United States; both the treatment being considered and the patient’s state limit the options. The compounded preparation has no FDA approval. This page remains a reading of the pharmacokinetic record rather than a treatment protocol.
What remains after tesamorelin leaves the blood
Tesamorelin itself left the blood quickly. Researchers gave that fall a calculated rate of 1,060 liters per hour. The figure does not mean liquid moved through a person; it only says the blood level dropped very fast. By day 14, tests showed the body absorbed about 13% more of each dose than on day 1 [6].
The rise in growth hormone and IGF-1, a liver-made growth protein, lasted longer. That helps explain the daily shot used in the studies [4]. Little tesamorelin remained by the next day.